Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer's and Pick's disease

被引:35
|
作者
Miguel, RF [1 ]
Pollak, A [1 ]
Lubec, G [1 ]
机构
[1] Med Univ Vienna, Dept Pediat, CChem FRSC UK, A-1090 Vienna, Austria
来源
MOLECULAR BRAIN RESEARCH | 2005年 / 133卷 / 01期
关键词
metalloproteinase; ADAMTS; neurodegeneration; Down syndrome; Alzheimer's disease; Pick's disease;
D O I
10.1016/j.molbrainres.2004.09.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
ADAMTS- 1 is a disintegrin and metalloproteinase with thrombospondin 1 (TSP 1)-like motifs with ubiquitous though variable expression. Natural substrates of this protease are proteoglycans as aggrecan and versican and null mutant mice propose a role for growth, fertility, organ structure and function. As the gene for this protein is encoded on chromosome 21 and maybe overexpressed due to the gene dosage hypothesis based upon the presence of a third chromosome in trisomy 2 1, we decided to study expression in Down syndrome (DS) brain and used brains of patients with Alzheimer's (AD) and Pick's disease (PD) as controls. Frontal cortex of controls, DS, AD and PD were homogenized and extracted proteins were used for immumoblotting using antibodies against ADAMTS-1 and ADA-MTS-5. ADAMTS-1-immunoreactivity was manifold increased in brain with DS and neurodegeneration, whereas ADAMTS-5 levels were comparable. Overexpression of this metalloproteinase maybe specifically involved in proteoglycan degradation and handling in brain of patients with neurodegenerative disease which in turn may lead to or reflect pathological lesions in DS, AD and PD brain. The manifold overexpression of ADAMTS-I may be used as marker protein for neurodegeneration. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [41] BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (B): 3-Amino-4-fluoro-1H-isoindol Derivatives
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (11): : 869 - 870
  • [42] Sphingosine-1-phosphate receptor type 5 (S1P5) agonism: A potential new mechanism for the treatment of neuronopathic features of Niemann-Pick disease type C and neurodegenerative sphingolipidoses
    France, Nicholas
    Liu, Enchi
    Carlisle, Holly
    Barlow, Carrolee
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S58 - S59
  • [43] Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome (vol 101, pg S95, 2024)
    Meijer, L.
    Chretien, E.
    Ravel, D.
    JOURNAL OF ALZHEIMERS DISEASE, 2025, 103 (03) : 975 - 975
  • [44] MiR-409-5p as a Regulator of Neurite Growth Is Down Regulated in APP/PS1 Murine Model of Alzheimer's Disease
    Guo, Jing
    Cai, Yifei
    Ye, Xiaoyang
    Ma, Nana
    Wang, Yuan
    Yu, Bo
    Wan, Jun
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [45] Th1 responses to beta-amyloid in young humans convert to regulatory IL-10 responses in Down syndrome and Alzheimer's disease
    Loewenbrueck, Kai F.
    Tigno-Aranjuez, Justine T.
    Boehm, Bernhard O.
    Lehmann, Paul V.
    Tary-Lehmann, Magdalena
    NEUROBIOLOGY OF AGING, 2010, 31 (10) : 1732 - 1742
  • [46] Bidirectional Regulation of Amyloid Precursor Protein-Induced Memory Defects by Nebula/DSCR1: A Protein Upregulated in Alzheimer's Disease and Down Syndrome
    Shaw, Jillian L.
    Zhang, Shixing
    Chang, Karen T.
    JOURNAL OF NEUROSCIENCE, 2015, 35 (32): : 11374 - 11383
  • [47] Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease
    Shim, KS
    Ferrando-Miguel, R
    Lubec, G
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2003, (67): : 39 - 49
  • [48] RCAN1 knockout and overexpression recapitulate an ensemble of rest-activity and circadian disruptions characteristic of Down syndrome, Alzheimer’s disease, and normative aging
    Helen Wong
    Jordan M. Buck
    Curtis Borski
    Jessica T. Pafford
    Bailey N. Keller
    Ryan A. Milstead
    Jessica L. Hanson
    Jerry A. Stitzel
    Charles A. Hoeffer
    Journal of Neurodevelopmental Disorders, 2022, 14
  • [49] RCAN1 knockout and overexpression recapitulate an ensemble of rest-activity and circadian disruptions characteristic of Down syndrome, Alzheimer's disease, and normative aging
    Wong, Helen
    Buck, Jordan M.
    Borski, Curtis
    Pafford, Jessica T.
    Keller, Bailey N.
    Milstead, Ryan A.
    Hanson, Jessica L.
    Stitzel, Jerry A.
    Hoeffer, Charles A.
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2022, 14 (01)
  • [50] Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome
    Patel, Ashok
    Rees, Simon D.
    Kelly, M. Ann
    Bain, Steven C.
    Barnett, Anthony H.
    Thalitaya, Deepak
    Prasher, Vee P.
    NEUROSCIENCE LETTERS, 2011, 487 (02) : 144 - 148